ask="7.2000"
ask_size="700"
average_daily_volume="46724"
bid="N/A"
bid_size="N/A"
book_value="5.0780"
change="+0.0987"
change_from_200_day_moving_average="-1.5492"
change_from_50_day_moving_average="-0.7352"
change_from_52_week_high="-8.6613"
change_From_52_week_low="0.4287"
change_in_percent="+2.4737%"
close="4.0887"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.0580"
ebitda="-20.26M"
eps_estimate_current_year="-8.6100"
eps_estimate_next_quarter="-0.8000"
eps_estimate_next_year="-2.5700"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.1000"
high_52_weeks="12.7500"
last_trade_date="2/1/2017"
last_trade_price="4.0887"
last_trade_size="500"
last_trade_time="3:59pm"
low="3.8318"
low_52_weeks="3.6600"
market_capitalization="54.91M"
moving_average_200_day="5.6379"
moving_average_50_day="4.8239"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.0000"
open="4.0000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-27.4787%"
percent_change_from_50_day_moving_average="-15.2410%"
percent_change_from_52_week_high="-67.9318%"
percent_change_from_52_week_low="+11.7131%"
previous_close="3.9900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.7857"
price_per_sales="10.7905"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="1.4200"
stock_exchange="NGM"
symbol="AGLE"
volume="46753"
weeks_range_52="3.6600 - 12.7500"
